This is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Wednesday, September 28, 2011
Soviet-era pill from Bulgaria helps smokers quit; its low price holds hope for poor countries
A pill developed in Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big study of it shows. It could become a new weapon to combat smoking in poor countries, but it is unclear whether it will ever reach the market in the U.S. or Western Europe. The drug, cytisine, is now used just in Eastern Europe, where smokers usually take the pill for three or four weeks. Generic versions cost as little as $5 to $17 a month, compared with about $100 for an eight-week supply of nicotine patches or about $300 for a 12-week supply of Pfizer Inc.'s Chantix pill - common treatments in rich countries to help smokers quit. Cytisine "is so cheap that even in developing countries, if you can afford to smoke, you can afford to stop," said Dr. Robert West of University College London. He led the study, published in Thursday's New England Journal of Medicine
Implantable pacemaker inventor Wilson Greatbatch dies
Sunday, September 25, 2011
Thursday, September 22, 2011
Seasonal Influenza Immunization begins on October 11, 2011
People at high risk of complications or hospitalization:
* People 65 years of age or older (or turn 65 prior to March 31, 2012)
* Pregnant women
* Children 6 months to 4 years of age
* People who are severely obese
* People of any age who are residents of nursing homes and other chronic care facilities
* Anyone with chronic health conditions
Household and close contacts:
* Of any of the categories listed above
* Of infants less than 6 months of age
* Households expecting a newborn before March 31, 2012
Other groups:
* Healthcare providers, health care students and registered volunteers
* Physicians and medical office staff
* People providing regular child care to children less than 5 years of age
* People employed in the poultry and hog industry
If you have any questions, contact the Saskatoon Health Region at 655-4620
Food Chat with Rochelle Anthony
Do have a question for Rochelle Anthony, Dietitian for the Cardiac Rehab Program? Dates:
Field House:
Wednesday October 5 @ 9am - 11am
Thursday November 24 @ 9am - 10:30am
Wednesday December 7 @ 9am - 11am
Shaw Centre:
Wednesday November 30 @ 9am - 11am
(Please note that Jackie Boschman, Cardiac Rehab Nurse, will be present on this day)
Field House:
Wednesday October 5 @ 9am - 11am
Thursday November 24 @ 9am - 10:30am
Wednesday December 7 @ 9am - 11am
Shaw Centre:
Wednesday November 30 @ 9am - 11am
(Please note that Jackie Boschman, Cardiac Rehab Nurse, will be present on this day)
Diabetes on Track - do you have a question regarding your diabetes?
Marlene Matiko, Diabetes Nurse Educator, and Rochelle Anthony, Dietitian, will be in the track area to answer your questions on:
Field House:
Tuesday October 25 @ 8am - 10am
Monday November 7 @ 8am - 11am
Shaw Centre:
Wednesday October 19 @ 8am - 11am
Please bring your logbook and blood sugar meter. No appointments required but you may book a time. Speak to your exercise therapist about this
Field House:
Tuesday October 25 @ 8am - 10am
Monday November 7 @ 8am - 11am
Shaw Centre:
Wednesday October 19 @ 8am - 11am
Please bring your logbook and blood sugar meter. No appointments required but you may book a time. Speak to your exercise therapist about this
Craving Change(TM) - changing your relationship with food
Understand why you eat the way you do:
Comfort yourself without food - Change your thinking - Change your eating
2 programs available:
Field House:
Thursday October 6 @ 10am - 12pm
Thursday October 20 @ 10am - 12pm
Thursday November 3 @ 10am - 12pm
West Winds:
Tuesday October 18 @ 2pm - 4pm
Tuesday October 25 @ 2pm - 4pm
Tuesday November 8 @ 2pm - 4pm
Please call 655-LIVE or 655-5483 to register
Let's talk about your Diabetes
Join us for a Conversation Map™:
* you learn from others just like you
* share your thoughts and experiences
* Three part session: October, 25; November 8 & 22
* All sessions are 10:30am - 12:30pm at meeting room #2 upstairs at the Field House
* Lunch will be provided
* Facilitators : Marlene Matiko, Diabetes Nurse Clinician and Rochelle Anthony, Dietitian (Phone: 655-2140)
* To register, or for more information, talk to your exercise therapist. Space is limited
Wednesday, September 21, 2011
Possible new blood test to diagnose heart attacks (USA)
Loyola University Chicago Stritch School of Medicine researchers are reporting a possible new blood test to help diagnose heart attacks. In the Journal of Molecular and Cellular Cardiology, researchers report that a large protein known as cardiac myosin binding protein-C (cMyBP-C) is released to the blood following a heart attack. "This potentially could become the basis for a new test, used in conjunction with other blood tests, to help diagnose heart attacks," said senior author Sakthivel Sadayappan, PhD. "This is the beginning. A lot of additional studies will be necessary to establish cMyBP-C as a true biomarker for heart attacks."
Tuesday, September 20, 2011
The Melville Communiplex Project Fitness Centre (Saskatchewan)
Monday, September 19, 2011
WHO targets non-communicable 'lifestyle' diseases
The World Health Organization has set out a plan to tackle non-communicable diseases like heart disease, which now pose a greater global burden than infectious diseases. "Lifestyle-related" diseases are now the leading cause of death worldwide, killing 36 million people a year. Much of the toll is in low and middle-income countries and this is where efforts must be focused, says WHO. It suggests affordable steps governments should take. The list includes measures that target the population as a whole, such as excise taxes on tobacco and alcohol, smoke-free indoor workplaces and public places, as well as campaigns to reduce salt and dangerous fats in foods. Other tactics focus on individuals and include screening and treatment for cardiovascular disease and cervical cancer, as well as immunisation against hepatitis B to prevent liver cancer. WHO estimates the total cost for adopting these strategies in all low-and middle-income countries would be $11.4bn (£7.2bn) per year
Sunday, September 18, 2011
Olive Garden, other restaurants set to offer healthier meals (USA)
Whitehall targets threaten the Great British Breakfast (UK)
Eyelid marks warn of heart attack (Denmark)
Thursday, September 15, 2011
Elizabeth Banks has heart attack for a cause (USA)
Elizabeth Banks has teamed up with the American Heart Association to put out a funny little public service announcement in support of heart wellness issues. In the video, part of the association's Go Red for Women campaign, Banks plays an over-stressed mom busy taking care of everything around her house while neglecting her own heart. Humor is a good way of broaching difficult subjects and the video combines serious facts along with a touch of Banks' Emmy-nominated flair. Heart disease is the number one killer of American women, according to the American Heart Association. It's also a personal issue for Banks. Her mother, father and sisters all suffer from heart disease. As a new mother, Banks says it's important for her to stay healthy for her son
Apple a day 'keeps strokes away'
Wednesday, September 14, 2011
Million Hearts (USA)
New IDF data reveals diabetes epidemic continues to escalate
New Diabetes Atlas figures released by the International Diabetes Federation confirm that the diabetes epidemic continues to worsen. Data from global studies demonstrates that the number of people with diabetes in 2011 has reached a staggering 366 million, 4.6 million deaths are due to diabetes and health care spending on diabetes has reached 465 billion USD
Sunday, September 11, 2011
Smoking in Canada hits all-time low in 2010
According to new statistics the smoking rate in Canada has dropped to 17% in 2010. This is the lowest level ever recorded, according to annual results of the 2010 Canadian Tobacco Use Monitoring Survey. "The numbers announced today are encouraging, as they show more Canadians are making the healthy choice when it comes to smoking," said the Honourable Leona Aglukkaq, Minister of Health. "I am particularly encouraged by the numbers when it comes to youth." According to the 2010 survey, smoking rates have significantly declined for key age groups. For example, in 2010 smoking among teens aged 15 to 17 fell to 9% - the lowest recorded rate in an age group often seen as key in the fight against smoking. CTUMS, a national survey conducted by Statistics Canada on behalf of Health Canada since 1999, provides essential input to the development of sound and effective tobacco control policies and programs, as well as their evaluation
Wednesday, September 7, 2011
Heart scan could replace angiogram for some patients
Monday, September 5, 2011
Mesoblast receives clearance to begin first European trial of allogeneic or 'off-the-shelf' stem cell treatment for heart attacks
Global regenerative medicine company, Mesoblast Limited has announced that it had received clearance from the European Medicines Agency to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor(TM) is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction)
Scripps Research scientists establish new class of anti-diabetic compound
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. The finding paves the way for the development of anti-diabetic therapeutics with minimal adverse side effects plaguing currently available drugs such as Avandia (rosiglitazone), scheduled to be removed from pharmacy shelves this fall due to concerns about increased risk of heart attack. The new study, led by Patrick R. Griffin, professor and chair of the Department of Molecular Therapeutics at Scripps Florida, Bruce Spiegelman, professor of cell biology at the Dana-Farber Cancer Institute, and Theodore Kamenecka, associate scientific director of medicinal chemistry at Scripps Florida, was published September 4, 2011, in the journal Nature. The study describes a new compound known as SR1664
Sunday, September 4, 2011
Longer CPR not necessarily beneficial: study (Canada)
Saturday, September 3, 2011
Opticians 'should offer blood sugar checks' (UK)
US stroke rates 'rising in young'
Thursday, September 1, 2011
UK stem cell stroke trial passes first safety test
The world's first clinical trial of brain stem cells to treat strokes is set to move to its next phase. An independent assessment of the first three patients to have had stem cells injected into their brain at Glasgow's Southern General Hospital has concluded it has had no adverse effect. The assessment paves the way for the therapy to be tested on more patients to find a new treatment for stroke. The hope is that the stem cells will help to repair damaged brain tissue. The trial is being led by Prof Keith Muir of Glasgow University. He told BBC News that he was pleased with the results so far
Subscribe to:
Posts (Atom)